Quest Diagnostics Updates EPS Outlook For FY25, Stock Down In Pre-Market

(RTTNews) - Quest Diagnostics Inc. (DGX), Tuesday announced revised outlook for the financial year 2025.

The company now sees earnings between $8.62 and $8.87 per share instead of previously estimated $8.34 and $8.59 for the full year 2025.

Meanwhile, it anticipates adjusted earnings of $9.55 to $9.80 per share, and revenue of $10.70 billion to $10.85 billion for the same period.

Analysts, on average, estimates earnings of $9.69 per share, and revenue of $10.78 billion for the fiscal year 2025.

In the pre-market hours, DGX is trading at $163.15, up 0.80 percent on the New York Stock Exchange.